Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

Document › Details

AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]".

	Organisation	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Organisation 2	Alexion Pharmaceuticals Inc. (Nasdaq: ALXN)
	Group	AstraZeneca (Group)
	Product	DRUGS, ORPHAN
	Product 2	pharmaceutical
	Index term	Alexion–AstraZeneca: investment, 202012– acquisition $39b with $13.4b in cash + $25.6b in ADSs Alexion shareholders will own 15% of combined firm
	Person	Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
	Person 2	Hantson, Ludwig Norbert Michel (Alexion 201703– CEO before Baxalta/Baxter)

Original document
accessed by [iito] on 2020-12-13

Record changed: 2020-12-23

More documents for AstraZeneca (Group)

[1] ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin....
[2] Neurimmune AG. (1/7/22). "Press Release: Neurimmune Enters into a Collaboration and License Agreement with AstraZeneca to Develop and Commercialize NI006". Zürich....
[3] Amphista Therapeutics Ltd.. (12/6/21). "Press Release: Amphista Therapeutics Appoints Dr Martin Pass as CDO". Cambridge....
[4] AstraZeneca plc. (11/1/21). "Press Release: AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma"....
[5] AstraZeneca plc. (9/23/21). "Press Release: AstraZeneca to Discover and Develop Self-amplifying RNA Therapeutics in New Collaboration with VaxEquity. AstraZeneca Will Invest in VaxEquity, an Imperial College Spin-off"....
[6] VaxEquity Ltd.. (9/23/21). "Press Release: VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform". London....
[7] EQRx, Inc.. (8/18/21). "Press Release: EQRx Appoints Richard Buckley as Chief Corporate Affairs Officer"....
[8] Proteros Biostructures GmbH. (6/2/21). "Press Release: Proteros Enters into Oncology Collaboration and License Agreement with AstraZeneca". Martinsried....
[9] Immunocore Holdings plc. (2/16/21). "Press Release: Immunocore Announces Key Appointments to Management and Board". Oxfordshire & Conshohocken, PA....
[10] AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top